$OLMA

$6.62 +$0.21 (3.28%) Close

$OLMA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 87.5M shares outstanding

Who owns OLMA?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 138.7%

BlackRock, Inc. 25.1% · FMR LLC 24.2%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

282

-11 vs last qtr

Net shares bought

+2.2M

by institutions in Q2 2026

New / sold out

43 / 54

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +7.1M
BlackRock, Inc. +2.5M

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −7.3M
Ra Capital Management, L.P. SOLD OUT −2.6M

Who is planning to sell?

Notices of proposed sale, last 12 months

$33.5M

28 notices from 6 people

Shares covered

1.4M

1.62% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Kovacs Shane William Charles Former officer $11.7M
Clark Ian T Director $7.87M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2019–FY2025

+3255.0%

+79.59% a year

Each share's claim on the business

−97.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $95.3M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years45% 3–5 years28% 1–3 years12% Under 1 year15%

Quarterly turnover

15.0%

of institutional shares changed hands

Top 10 managers, median time held

4.5 years

Super Investors

Investment managers reporting OLMA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	21.9M	25.07%	+2.5M (+13.1%)	≤2021	0.0%
Shares held by quarter Peak holding21.9M (Q2'26) Change over 8 quarters+3.2M Share of the company25.070% BlackRock, Inc.'s full portfolio →
F FMR LLC	21.2M	24.18%	−143.2K (−0.7%)	≤2021	0.0%
Shares held by quarter Peak holding21.3M (Q1'26) Change over 8 quarters+11.9M Share of the company24.180% FMR LLC's full portfolio →

BlackRock, Inc.

21.9M

% of company

25.07%

Change vs last qtr

+2.5M (+13.1%)

Held since

≤2021

FMR LLC

21.2M

% of company

24.18%

Change vs last qtr

−143.2K (−0.7%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Olema Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting OLMA on Form N-PORT; together they hold 97.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Metals & Mining ETF SPDR Series Trust	$76.2M	7.9M	9.06%	1.74%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$71.4M	6.6M	7.59%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Metals & Mining ETF

SPDR Series Trust

Position value

$76.2M

% of company

9.06%

% of the fund

1.74%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$71.4M

% of company

7.59%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Olema Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LM Lampert Mark N 5%+ holder 13D · 9.8%	8.9M	10.22%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.220% Disclosed stake13D · 9.8% View the 13D/G filing →
BP BVF Partners L P/il 5%+ holder 13D · 9.8%	8.9M	10.22%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company10.220% Disclosed stake13D · 9.8% View the 13D/G filing →

Lampert Mark N

5%+ holder13D · 9.8%

8.9M

% of company

10.22%

Change vs last qtr

—

Held since

—

BVF Partners L P/il

5%+ holder13D · 9.8%

8.9M

% of company

10.22%

Change vs last qtr

—

Held since

—

18 more holders behind a free account

See every insider and 5%+ holder of Olema Pharmaceuticals Inc.

Comments